GROUP ONE TRADING, L.P. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is and the CUSIP is G6674U958. A total of 6 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$350,455
-89.6%
21,700
-73.2%
0.00%
-90.9%
Q2 2023$3,361,500
-12.0%
81,000
+27.6%
0.01%
-21.4%
Q1 2023$3,818,890
-70.6%
63,500
-64.1%
0.01%
-53.3%
Q4 2022$12,982,950
+78.6%
177,000
+85.0%
0.03%
+114.3%
Q3 2022$7,271,000
+43.9%
95,700
+31.6%
0.01%
+75.0%
Q2 2022$5,053,000
-24.6%
72,700
-10.1%
0.01%
+14.3%
Q1 2022$6,703,000
-23.0%
80,900
-30.2%
0.01%0.0%
Q4 2021$8,702,000
-25.2%
115,900
+15.8%
0.01%
-46.2%
Q3 2021$11,629,000
-28.8%
100,100
+36.0%
0.01%
-35.0%
Q2 2021$16,326,000
+154.1%
73,600
+51.4%
0.02%
+100.0%
Q1 2021$6,424,000
+3.7%
48,600
+35.8%
0.01%
-9.1%
Q4 2020$6,195,000
+43.1%
35,800
-8.0%
0.01%
-21.4%
Q3 2020$4,330,000
+205.6%
38,900
+62.8%
0.01%
+100.0%
Q2 2020$1,417,000
+46.1%
23,900
+66.0%
0.01%
-12.5%
Q1 2020$970,000
+139.5%
14,400
+200.0%
0.01%
+166.7%
Q4 2019$405,000
-83.0%
4,800
-85.0%
0.00%
-84.2%
Q3 2019$2,385,000
-19.4%
31,900
-31.8%
0.02%
-29.6%
Q2 2019$2,959,000
+860.7%
46,800
+631.2%
0.03%
+800.0%
Q1 2019$308,000
+27.8%
6,400
-11.1%
0.00%
+50.0%
Q4 2018$241,000
-58.6%
7,200
-35.1%
0.00%
-60.0%
Q3 2018$582,000
+676.0%
11,100
+362.5%
0.01%
+400.0%
Q2 2018$75,000
-3.8%
2,400
-33.3%
0.00%0.0%
Q1 2018$78,000
+13.0%
3,600
+5.9%
0.00%
Q4 2017$69,000
-10.4%
3,400
-12.8%
0.00%
-100.0%
Q3 2017$77,000
+54.0%
3,900
+34.5%
0.00%0.0%
Q2 2017$50,000
+177.8%
2,900
+31.8%
0.00%
Q1 2017$18,000
+350.0%
2,200
+340.0%
0.00%
Q4 2016$4,000
-95.9%
500
-95.6%
0.00%
-100.0%
Q3 2016$97,000
+1112.5%
11,400
+1528.6%
0.00%
Q2 2016$8,0007000.00%
Other shareholders
NOVOCURE LTD shareholders Q3 2021
NameSharesValueWeighting ↓
PURA VIDA INVESTMENTS, LLC 64,100$7,446,0000.23%
GROUP ONE TRADING, L.P. 100,100$11,629,0000.01%
HBK INVESTMENTS L P 18,000$2,091,0000.01%
SIMPLEX TRADING, LLC 10,700$2,030,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
JPMORGAN CHASE & CO 1,000$116,0000.00%
View complete list of NOVOCURE LTD shareholders